Expert Analysis - Opinion

Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

Meta Privacy Verdict Raises Stakes For Website Data Tracking No Photo Available

Allison Grande

A California federal jury's move to hold Meta accountable for unauthorized receipt of sensitive health data gathered through a popular... (more story)

States Push Anti-mRNA Bills Amid Growing Public Distrust No Photo Available

Mark Payne

Public distrust was a key motivator for the federal government's decision to cut contracts developing messenger RNA vaccines. The sent... (more story)

New Barriers To Health Safety Net Spark Questions, Litigation No Photo Available

Gianna Ferrarin

Federal health officials' reinterpretation of a decades-old social welfare law is expected to boot thousands of noncitizens from safet... (more story)